Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 10.28%
- Poor long term growth as Net Sales has grown by an annual rate of 12.60% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.93 times
Despite the size of the company, domestic mutual funds hold only 0% of the company
Total Returns (Price + Dividend) 
Mukka Proteins for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Mukka Proteins Ltd is Rated Sell by MarketsMOJO
Mukka Proteins Ltd is rated Sell by MarketsMOJO, with this rating last updated on 20 November 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 November 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Mukka Proteins Ltd Locks at Lower Circuit With 3.27% Loss — Sellers Queue, No Buyers in Sight
At Rs 26.42, sellers were still queuing — but there were no buyers willing to take the other side. Mukka Proteins Ltd locked at its lower circuit of 3.27% on 11 Nov 2026, with unfilled sell orders and a frozen price that capped losses for the day.
Read More
Mukka Proteins Ltd is Rated Hold by MarketsMOJO
Mukka Proteins Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 November 2026, providing investors with the most recent insights into its performance and outlook.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Investor Presentation
10-Nov-2026 | Source : BSEIntimation of Investor Presentation - Q2 & FY-27.
Announcement under Regulation 30 (LODR)-Newspaper Publication
09-Nov-2026 | Source : BSEIntimation of newspaper publication of financial results.
Financial Results For The Quarter And Half Year Ended 30Th September 2026.
07-Nov-2026 | Source : BSEFinancial Results for the quarter and half year ended 30th September 2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 4 FIIs (1.7%)
Mohammed Haris K (30.23%)
Craft Emerging Market Fund Pcc- Elite Capital Fund (1.19%)
23.21%
Quarterly Results Snapshot (Consolidated) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 3.93% vs 28.65% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is -15.35% vs -8.39% in Jun 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 29.11% vs -46.92% in Sep 2024
Growth in half year ended Sep 2025 is 12.14% vs -79.62% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 71.06% vs -44.36% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -5.21% vs -23.27% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 44.02% vs -27.06% in Mar 2025
YoY Growth in year ended Mar 2026 is 12.05% vs -33.68% in Mar 2025